ArticleAnnals of African medicine2026
Quality of Life of Patients with End-stage Renal Disease Undergoing Hemodialysis in Morocco: Cross-sectional Study.
Article in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnd-stage chronic renal disease and its long-term treatment by hemodialysis (HD) affect several aspects of life. This is a cross-sectional, descriptive, and analytical study of 80 patients undergoing chronic HD at the only public sector HD center in the Meknes prefecture of Morocco. This study's objectives are to evaluate the quality of life (QOL) of patients receiving chronic HD and to determine the factors associated with these patients' decreased QOL. SUBJECTS AND
methodsTo achieve the aims of this study, the short form of the Kidney disease quality of life short form (KDQOL-SF1,3), translated and validated in the Moroccan context, was the data collection instrument utilized to gauge these patients' QOL.
resultsThe overall mean KDQOL-SF™ score was 39.31 (standard deviation [SD] 7.56). The kidney disease component, mental component, and physical component scores were 47.84 (SD 11), 33.91 (SD 10.22), and 36.19 (SD 8.30), respectively. Scores considered satisfactory were in favor of social support. Similarly, this study revealed, using the Student's t -test, that there was no significant difference in the means between the subgroups in terms of age, sex, marital status, and duration of HD treatment, while it revealed a significant correlation, using the Pearson's test, between kidney disease component and the two physical health and mental health components.
conclusionsThis study revealed that the QOL of chronic HD patients is impaired. It highlighted that an action on the effects of kidney disease could improve the physical and mental health and, consequently, the QOL of HD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.